Aliasger K. Salem

10.6k citations
230 papers · 8.0k indexed · 3 hit papers · h-index 49

Impact in

  • Biomaterials top 0.5%
    • Nanoparticle-Based Drug Delivery
    • Electrospun Nanofibers in Biomedical Applications
    • Bone Tissue Engineering Materials
    • 3D Printing in Biomedical Research
    • Nanoplatforms for cancer theranostics

Papers in

    • Immunotherapy and Immune Responses 49
    • Immune Cell Function and Interaction 20
    • Nanoparticle-Based Drug Delivery 19

Aliasger K. Salem

219 papers receiving 7.9k citations

Hit Papers

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics 2021 · 188 citations
1882003202620102018200400600

Peers

Aliasger K. Salem
Comparison fields: 5 of 162
  • Biomaterials 1.7k
  • Biomedical Engineering 3.0k
  • Pharmaceutical Science 402
  • Immunology 1.3k
  • Automotive Engineering 513
Replace Krishnendu Roy with:
Krishnendu Roy United States
C. F. Xu China
Yang Liu China
Amir M. Ghaemmaghami United Kingdom
Lonnie D. Shea United States
Cory Berkland United States
Jiacan Su China
Weiwei Wang China
Min Liu China
Lei Zhang China
Aliasger K. Salem relative to Krishnendu Roy United States Krishnendu Roy's profile →
Citations per field
00.5×1.5×1.9×
Krishnendu Roy · 1×
Citations per year

Countries citing papers authored by Aliasger K. Salem

Since Specialization
Citations

This map shows the geographic impact of Aliasger K. Salem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliasger K. Salem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliasger K. Salem more than expected).

Fields of papers citing papers by Aliasger K. Salem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aliasger K. Salem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliasger K. Salem. The network helps show where Aliasger K. Salem may publish in the future.

Co-authors

The 25 scholars most cited alongside Aliasger K. Salem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aliasger K. Salem Line = papers co-authored together Aliasger K. Salem links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20243
4 20240
5 20232
6 20238
7 202312
8 202311
9 20235
10 20226
11 20220
12 202227
13 20215
14 202112
15 20215
16 202014
17 202013
18 202014
19 201884
20 201511

About Aliasger K. Salem

Aliasger K. Salem is a scholar working on Immunology, Biomaterials, Pharmaceutical Science, Biomedical Engineering and Molecular Biology, having authored 230 papers that have together received 8.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (60 papers), Immunotherapy and Immune Responses (49 papers), Bone Tissue Engineering Materials (26 papers), Immune Cell Function and Interaction (20 papers), 3D Printing in Biomedical Research (20 papers), Nanoparticle-Based Drug Delivery (19 papers), Advanced biosensing and bioanalysis techniques (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Biomaterials (1.7k citations), Biomedical Engineering (3.0k citations), Pharmaceutical Science (402 citations), Immunology (1.3k citations) and Automotive Engineering (513 citations). Aliasger K. Salem has collaborated with scholars based in United States, Egypt and Thailand. Frequent co-authors include Sean M. Geary, Kam W. Leong, Peter C. Searson, Behnoush Khorsand, Anh‐Vu Do, Janjira Intra, Vijaya B. Joshi, Yogita Krishnamachari, Satheesh Elangovan and Timothy M. Acri. Their work appears in journals such as The AAPS Journal, Journal of Pharmaceutical Sciences, Molecular Pharmaceutics, International Journal of Pharmaceutics and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026